5.00
price up icon3.52%   0.17
after-market Handel nachbörslich: 5.00
loading

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

pulisher
Nov 12, 2024

Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewswire

Nov 12, 2024
pulisher
Nov 11, 2024

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - GlobeNewswire Inc.

Nov 11, 2024
pulisher
Nov 08, 2024

TSX Composite Capped Index (TOOC) QuotePress Release - The Globe and Mail

Nov 08, 2024
pulisher
Nov 06, 2024

AgeX Therapeutics stock hits 52-week low at $5.72 - Investing.com India

Nov 06, 2024
pulisher
Nov 06, 2024

AgeX Therapeutics stock hits 52-week low at $5.72 By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Oct 02, 2024

Serina Therapeutics CDO Presents at Injectables Summit - TipRanks

Oct 02, 2024
pulisher
Oct 02, 2024

Serina Therapeutics to Present at the 14th Annual Injectables Summit - GlobeNewswire

Oct 02, 2024
pulisher
Sep 25, 2024

SLM initiated with a Buy at BofA - TipRanks

Sep 25, 2024
pulisher
Sep 25, 2024

Serina Therapeutics director buys $6.9k in company stock By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 24, 2024

Serina Therapeutics director buys $6.9k in company stock - Investing.com India

Sep 24, 2024
pulisher
Sep 24, 2024

Biotech Soars On Material Transfer Agreement - Invezz

Sep 24, 2024
pulisher
Sep 24, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Sep 24, 2024
pulisher
Sep 24, 2024

Seelos Therapeutics Inc Inc. (SEEL) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Sep 24, 2024
pulisher
Sep 24, 2024

Savaria (TSE:SIS) Trading Down 4.1% - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

SThree Q3 net fees slip 8% amid challenging conditions - Staffing Industry Analysts

Sep 24, 2024
pulisher
Sep 24, 2024

UK recruiter SThree falls on lower Q3 net fee - XM

Sep 24, 2024
pulisher
Sep 24, 2024

SThree plc Navigates Market Headwinds in Q3 - TipRanks

Sep 24, 2024
pulisher
Sep 23, 2024

Serabi Gold (LON:SRB) Reaches New 12-Month High at $91.97 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Quarterly Metrics: Quick and Current Ratios for SELLAS Life Sciences Group Inc (SLS) - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Ready to Jump After Recent Trade: SELLAS Life Sciences Group Inc (SLS) - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval - Benzinga

Sep 23, 2024
pulisher
Sep 21, 2024

Director Gregory Bailey Acquires 14,388 Shares of Serina Therapeutics Inc (SER) - Stockxpo

Sep 21, 2024
pulisher
Sep 20, 2024

Serina Therapeutics director buys $88.2k in company stock By Investing.com - Investing.com South Africa

Sep 20, 2024
pulisher
Sep 20, 2024

Serina Therapeutics director buys $88.2k in company stock - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Sanofi (NASDAQ: SNY) Secures FDA Approval for Multiple Myeloma Drug in Newly Diagnosed Patients - ABBO News

Sep 20, 2024
pulisher
Sep 13, 2024

Serina Therapeutics appoints new CEO with strategic goals By Investing.com - Investing.com Australia

Sep 13, 2024
pulisher
Sep 13, 2024

Serina Therapeutics appoints new CEO with strategic goals - Investing.com

Sep 13, 2024
pulisher
Sep 12, 2024

Serina Therapeutics Names Steven Ledger as Permanent CEO - TipRanks

Sep 12, 2024
pulisher
Sep 05, 2024

Serina Therapeutics Interim CEO Attends Global Investment Conference - TipRanks

Sep 05, 2024
pulisher
Sep 04, 2024

Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 04, 2024
pulisher
Aug 22, 2024

Serina Therapeutics director buys $14.7k in company stock - Investing.com

Aug 22, 2024
pulisher
Aug 21, 2024

Serina Therapeutics director buys $140k in company stock - Investing.com India

Aug 21, 2024
pulisher
Aug 20, 2024

Director Gregory Bailey Acquires 19,200 Shares of Serina Therapeutics Inc (SER) - Yahoo Finance

Aug 20, 2024
pulisher
Aug 16, 2024

Serina Therapeutics director buys $45k in company stock - Investing.com

Aug 16, 2024
pulisher
Aug 16, 2024

Serina Therapeutics Welcomes Gregory Curhan as New CFO - TipRanks

Aug 16, 2024
pulisher
Aug 09, 2024

Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewswire

Aug 09, 2024
pulisher
Jul 22, 2024

Nima Farzan named CEO of Latigo - BioCentury

Jul 22, 2024
pulisher
Jul 18, 2024

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation - GlobeNewswire

Jul 18, 2024
pulisher
Jul 10, 2024

Injectable Drug Delivery Market Size to Hit USD 1,630.73 Bn by 2033 - BioSpace

Jul 10, 2024
pulisher
May 22, 2024

Enable Injections makes C-suite move following slew of new partnershipsCincinnati Business Courier - Cincinnati Business Courier

May 22, 2024
pulisher
May 17, 2024

Enable Injections & Serina Partner to Develop Novel Parkinson’s Treatment - HIT Consultant

May 17, 2024
pulisher
May 15, 2024

Enable Injections and Serina Therapeutics Announce - GlobeNewswire

May 15, 2024
pulisher
May 14, 2024

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights - Yahoo Finance

May 14, 2024
pulisher
Apr 17, 2024

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman - GlobeNewswire

Apr 17, 2024
pulisher
Apr 02, 2024

Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving PremarketVirTra (NASDAQ:VTSI) - Benzinga

Apr 02, 2024
pulisher
Mar 27, 2024

Serina completes AgeX merger, targets neurological diseases and pain - Longevity.Technology

Mar 27, 2024
pulisher
Mar 26, 2024

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics - GlobeNewswire

Mar 26, 2024
pulisher
Mar 22, 2024

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results - Yahoo Finance

Mar 22, 2024
pulisher
Feb 27, 2024

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc.AGE - Business Wire

Feb 27, 2024
pulisher
Feb 07, 2024

AgeX Therapeutics Postpones Merger Completion with Serina - TipRanks

Feb 07, 2024
pulisher
Nov 20, 2023

Pfizer licenses small molecule drug delivery technology from Serina - Pharmaceutical Technology

Nov 20, 2023
pulisher
Nov 17, 2023

Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer - Yahoo Finance

Nov 17, 2023
pulisher
Nov 14, 2023

AgeX Therapeutics Reports Third Quarter 2023 Financial Results - Business Wire

Nov 14, 2023
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):